Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to -$15.6 million.

  • Integra Lifesciences Holdings' Cash from Investing Activities fell 4994.23% to -$15.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$77.4 million, marking a year-over-year increase of 8255.81%. This contributed to the annual value of -$390.8 million for FY2024, which is 31496.74% down from last year.
  • Per Integra Lifesciences Holdings' latest filing, its Cash from Investing Activities stood at -$15.6 million for Q3 2025, which was down 4994.23% from -$21.6 million recorded in Q2 2025.
  • Integra Lifesciences Holdings' Cash from Investing Activities' 5-year high stood at $14.8 million during Q3 2022, with a 5-year trough of -$322.2 million in Q2 2024.
  • In the last 5 years, Integra Lifesciences Holdings' Cash from Investing Activities had a median value of -$15.5 million in 2023 and averaged -$41.0 million.
  • Per our database at Business Quant, Integra Lifesciences Holdings' Cash from Investing Activities surged by 27469.03% in 2022 and then tumbled by 197227.94% in 2024.
  • Over the past 5 years, Integra Lifesciences Holdings' Cash from Investing Activities (Quarter) stood at -$27.5 million in 2021, then plummeted by 99.45% to -$54.8 million in 2022, then decreased by 4.39% to -$57.2 million in 2023, then surged by 92.58% to -$4.2 million in 2024, then plummeted by 266.86% to -$15.6 million in 2025.
  • Its last three reported values are -$15.6 million in Q3 2025, -$21.6 million for Q2 2025, and -$35.9 million during Q1 2025.